{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:25:28Z","timestamp":1768037128113,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jemermed.2017.05.037","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T14:04:17Z","timestamp":1505916257000},"page":"662-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Novel Therapies for Angiotensin-Converting Enzyme Inhibitor\u2013Induced Angioedema: A Systematic Review of Current Evidence"],"prefix":"10.1016","volume":"53","author":[{"given":"Heidi M.","family":"Riha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryant B.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica V.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan A.","family":"Van Berkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2017.05.037_bib1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jemermed.2013.03.045","article-title":"Angioedema: etiology, pathophysiology, current and emerging therapies","volume":"45","author":"Lewis","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1865-1380-5-39","article-title":"Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema","volume":"5","author":"Bernstein","year":"2012","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.amjmed.2007.09.024","article-title":"The spectrum and treatment of angioedema","volume":"121","author":"Tremi\u00f1o","year":"2008","journal-title":"Am J Med"},{"issue":"suppl 1","key":"10.1016\/j.jemermed.2017.05.037_bib4","first-page":"S47","article-title":"Hereditary and acquired angioedema","volume":"25","author":"Kim","year":"2004","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jemermed.2017.05.037_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(11)60935-5","article-title":"Hereditary angioedema","volume":"379","author":"Longhurst","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jemermed.2017.05.037_bib6","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1213\/ANE.0b013e3181d7ac98","article-title":"Hereditary angioedema: current and emerging treatment options","volume":"110","author":"Levy","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jemermed.2017.05.037_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjmed.2014.07.011","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema","volume":"128","author":"Bezalel","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.iac.2006.08.001","article-title":"Angiotensin-converting enzyme inhibitor-associated angioedema","volume":"26","author":"Byrd","year":"2006","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.jemermed.2017.05.037_bib9","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/HYPERTENSIONAHA.108.110270","article-title":"Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors","volume":"51","author":"Miller","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jemermed.2017.05.037_bib10","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.otohns.2007.08.012","article-title":"Clinical experience with angiotensin-converting enzyme inhibitor induced angioedema","volume":"137","author":"Grant","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jemermed.2017.05.037_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.jemermed.2017.05.037_bib12","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jemermed.2012.07.055","article-title":"Fresh frozen plasma for progressive and refractory angiotensin-converting enzyme inhibitor-induced angioedema","volume":"44","author":"Hassen","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1067\/mai.2002.121313","article-title":"Fresh-frozen plasma as a treatment for life-threatening ACE-inhibitor angioedema","volume":"109","author":"Karim","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jemermed.2017.05.037_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1081-1206(10)61766-8","article-title":"Fresh frozen plasma in the treatment of resistant angiotensin converting enzyme inhibitor angioedema","volume":"92","author":"Warrier","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jemermed.2017.05.037_bib15","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1016\/j.jemermed.2011.03.029","article-title":"Angiotensin converting enzyme inhibitor angioedema","volume":"43","author":"Bolton","year":"2012","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib16","article-title":"Fresh frozen plasma in the treatment of ACE inhibitor induced angioedema","volume":"23","author":"Stewart","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jemermed.2017.05.037_bib17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ccr3.171","article-title":"Angiotensin-converting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert\u00ae): about one case and review of the therapeutic arsenal","volume":"3","author":"Lipski","year":"2015","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.jemermed.2017.05.037_bib18","first-page":"92","article-title":"Life threatening angioedema in a patient on ACE inhibitor (ACEI) confined to the upper airway","volume":"2014","author":"Tharayil","year":"2014","journal-title":"Qatar Med J"},{"key":"10.1016\/j.jemermed.2017.05.037_bib19","first-page":"161","article-title":"Lingual Angioedema due to ACE-Inhibitor","volume":"2","author":"Shiber","year":"2014","journal-title":"Trop Med Surg"},{"key":"10.1016\/j.jemermed.2017.05.037_bib20","first-page":"642","article-title":"Angiotensin converting enzyme inhibitor, related angioedema: a case of an unexpected death","volume":"14","author":"Atalay","year":"2015","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.jemermed.2017.05.037_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1710-1492-6-24","article-title":"2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema","volume":"6","author":"Bowen","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jemermed.2017.05.037_bib22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.289.8.959","article-title":"Current and emerging infectious risks of blood transfusions","volume":"289","author":"Busch","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2017.05.037_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1081-1206(10)60886-1","article-title":"Fresh frozen plasma for the treatment of hereditary angioedema","volume":"98","author":"Prematta","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jemermed.2017.05.037_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jemermed.2007.02.024","article-title":"Effective treatment of hereditary angioedema with fresh frozen plasma in an emergency department","volume":"33","author":"Pekdemir","year":"2007","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/bja\/aes371","article-title":"Treatment of a life-threatening laryngeal bradykinin angio-oedema precipitated by dipeptidylpeptidase-4 inhibitor and angiotensin-1 converting enzyme inhibitor with prothrombin complex concentrate","volume":"109","author":"Millot","year":"2012","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jemermed.2017.05.037_bib26","series-title":"Berinert\u00ae [package insert]","year":"2015"},{"key":"10.1016\/j.jemermed.2017.05.037_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.anai.2013.06.021","article-title":"Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks","volume":"111","author":"Craig","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jemermed.2017.05.037_bib28","doi-asserted-by":"crossref","first-page":"e1939","DOI":"10.1097\/MD.0000000000001939","article-title":"Angioedema related to angiotensin-converting enzyme inhibitors: attack severity, treatment, and hospital admission in a prospective multicenter study","volume":"94","author":"Javaud","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jemermed.2017.05.037_bib29","doi-asserted-by":"crossref","first-page":"E198","DOI":"10.1002\/lary.25113","article-title":"Effect of C1-esterase-inhibitor in angiotensin-converting enzyme inhibitor-induced angioedema","volume":"125","author":"Greve","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jemermed.2017.05.037_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1399-6576.2005.00819.x","article-title":"Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate","volume":"50","author":"Nielsen","year":"2006","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jemermed.2017.05.037_bib31","article-title":"ACE-inhibitor induced angio-oedema treated with complement C1-inhibitor concentrate","volume":"4","author":"Rasmussen","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jemermed.2017.05.037_bib32","first-page":"3930923","article-title":"The use of plasma-derived complement c1-esterase inhibitor concentrate (Berinert\u00ae) in the treatment of angiotensin converting enzyme-inhibitor related angioedema","volume":"2016","author":"Hermanrud","year":"2016","journal-title":"Case Rep Emerg Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib33","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/j.jemermed.2015.06.076","article-title":"Use of C1-inhibitor for angiotensin-converting enzyme (ACE) inhibitor-induced angioedema decreases mechanical ventilation time","volume":"49","author":"Urnoski","year":"2015","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jaad.2010.03.023","article-title":"Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant","volume":"63","author":"Schmidt","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jemermed.2017.05.037_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.anai.2013.12.004","article-title":"Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3 randomized, placebo-controlled trial","volume":"112","author":"Riedl","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jemermed.2017.05.037_bib36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.anai.2010.04.012","article-title":"EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema","volume":"104","author":"Levy","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jemermed.2017.05.037_bib37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.annemergmed.2014.07.014","article-title":"Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial","volume":"65","author":"Lewis","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.anai.2014.12.007","article-title":"Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department","volume":"114","author":"Bernstein","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jemermed.2017.05.037_bib39","series-title":"Kalbitor [package insert]","year":"2015"},{"key":"10.1016\/j.jemermed.2017.05.037_bib40","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib41","doi-asserted-by":"crossref","first-page":"479.e1","DOI":"10.1016\/j.ajem.2014.08.055","article-title":"The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED","volume":"33","author":"Bartal","year":"2015","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib42","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00134-014-3290-z","article-title":"Angioedema induced by angiotensin converting enzyme inhibitors, potentiated by m-TOR inhibitors: successful treatment with icatibant","volume":"40","author":"Charmillon","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib43","first-page":"864815","article-title":"Icatibant in the treatment of angiotensin-converting enzyme inhibitor-induced angioedema","volume":"2014","author":"Crooks","year":"2014","journal-title":"Case Rep Crit Care"},{"key":"10.1016\/j.jemermed.2017.05.037_bib44","doi-asserted-by":"crossref","first-page":"1664.e1","DOI":"10.1016\/j.ajem.2011.09.014","article-title":"Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors","volume":"30","author":"Gallitelli","year":"2012","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-006646","article-title":"Icatibant and ACE inhibitor angioedema","volume":"2012","author":"Illing","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jemermed.2017.05.037_bib46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/imj.12659","article-title":"Drug safety in Aboriginal Australians: three cases of angiotensin-converting enzyme inhibitor angioedema","volume":"45","author":"Mahajan","year":"2015","journal-title":"Intern Med J"},{"key":"10.1016\/j.jemermed.2017.05.037_bib47","first-page":"386","article-title":"Bradykinin-receptor antagonist icatibant: possible treatment for ACE inhibitor-related angio-oedema","volume":"70","author":"Manders","year":"2012","journal-title":"Neth J Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib48","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5694\/mja15.01015","article-title":"Successful treatment of ACE inhibitor-induced angioedema with icatibant, a bradykinin B2 receptor antagonist","volume":"202","author":"Pucar","year":"2015","journal-title":"Med J Aust"},{"key":"10.1016\/j.jemermed.2017.05.037_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.transci.2011.11.011","article-title":"Angioedema: patients experience and treatment relief","volume":"46","author":"Kaeslin","year":"2012","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jemermed.2017.05.037_bib50","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.annemergmed.2010.03.032","article-title":"Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series","volume":"56","author":"Bas","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib51","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11739-015-1205-9","article-title":"Treatment of ACEI-related angioedema with icatibant: a case series","volume":"10","author":"Bova","year":"2015","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib52","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/imj.12849","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema and icatibant: a new hope","volume":"45","author":"Jacob","year":"2015","journal-title":"Intern Med J"},{"key":"10.1016\/j.jemermed.2017.05.037_bib53","article-title":"Using a bradykinin blocker in ACE inhibitor-associated angioedema in the emergency department","volume":"31","author":"Volans","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jemermed.2017.05.037_bib54","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/imj.12799","article-title":"Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema","volume":"45","author":"Fok","year":"2015","journal-title":"Intern Med J"},{"key":"10.1016\/j.jemermed.2017.05.037_bib55","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJMoa1312524","article-title":"A randomized trial of icatibant in ACE-inhibitor-induced angioedema","volume":"372","author":"Bas","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib56","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MEJ.0000000000000446","article-title":"Diagnosis and treatment of upper airway oedema caused by acute angio-oedema in the emergency department: a French consensus statement","volume":"24","author":"Floccard","year":"2017","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.jemermed.2017.05.037_bib57","unstructured":"Lexi-Comp, Inc. Lexicomp.com. Accessed September 24,\u00a02016."}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467917304894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467917304894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:38:19Z","timestamp":1760027899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467917304894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0736467917304894"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2017.05.037","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Therapies for Angiotensin-Converting Enzyme Inhibitor\u2013Induced Angioedema: A Systematic Review of Current Evidence","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2017.05.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}